Device Trial Radar · NCT05662501
Pleiades Safety and Feasibility Study
Last checked: Nov 20, 2026Latest source record: Feb 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
40
Planned (sponsor's estimate)
Start
Jan 10, 2024
Primary completion
May 30, 2024
Study completion Sep 30, 2024
Sponsor
- Lead sponsor
- PleioflowNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 22, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The "Pleiades" study is a non randomised, prospective, single center clinical trial that aims to evaluate the safety and the procedural feasibility of an innovative flow assist device (Pleioflow-RF) in adult patients undergoing elective cardiac surgery.
Conditions
- Elective Cardiac Surgery
Interventions
Pleioflow-RFDevice
Subjects who are going to undergo scheduled cardiac surgery and are prone to developing renal insufficiency, will receive the Pleioflow-RF device in conjunction with IABP during CPB. Subjects will be followed until 30-days post-intervention.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Feasibility of the Pleioflow-RF deviceTime frame: Through end of Device removal procedure
- Safety of the Pleioflow-RF deviceTime frame: Through end of Device removal procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Onassis Cardiac Center
Athens, Greece · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.